Report me for selling fake medicine? Why are you crying when your illness relapses?

After Chen Xuan's analysis,

Everyone thinks that $1000 billion in sales is not impossible.

Considering the market potential of lung cancer-specific drugs, this is highly likely to be achieved.

But even so, they don't think anyone would pay $1000 billion to acquire the formula.

Capital is meant to generate profits. If the returns are not big enough, they certainly would not spend $1000 billion to acquire a patent.

This kind of investment will take at least ten years to generate sufficient returns, so if the time cost is taken into account, it will cost at least $1500 billion.

Even for some capital pursuing high returns, at least they need to identify a specific drug for lung cancer that can generate $2000 billion in sales.

But the possibility is too low, and no capital dares to bet that these drugs for lung cancer can do the job.

Under such circumstances, a $1000 billion acquisition price is naturally impossible, which can only deter many pharmaceutical companies.

……

……

Mo Xuefeng also breathed a sigh of relief.

Because what Chen Xuan said meant that there was no possibility of selling the formula for the lung cancer drug.

For him, this is the result he most wants to see. He does not want the patent for the lung cancer drug to be sold to other pharmaceutical companies.

No matter how much the patent for the lung cancer drug is worth, it is best for it to remain in Chen Xuan's hands, and even domestic pharmaceutical companies should not get involved.

There are too many changes in the hands of other pharmaceutical companies, which is not conducive to benefiting more patients. It may even lead to the birth of truly sky-high priced drugs, which is the result that the Medical Insurance Bureau least wants to see.

For this reason, the best outcome is that there is no possibility of selling the patent now.

And at this moment, Chen Xuan dropped another bombshell.

"In the phase III clinical trial of a lung cancer drug,"

"We found that the lung cancer drug can also prevent and treat hepatitis B, and the effect is very obvious."

"All those who have participated in the clinical trial have acquired protective antibodies against hepatitis B, which protect the body from further attacks by the hepatitis B virus. At the same time, the hepatitis B patients have also been cured."

Chen Xuan slowly told this story.

This discovery was made in a phase I clinical trial.

It was only through continuous verification in Phase I, Phase II and Phase III clinical trials that these two functions were finally proven.

The specific drug for lung cancer can prevent and treat hepatitis B. This discovery has been confirmed by countless cases and is by no means just a possibility.

When he announced his discovery,

This left everyone stunned.

Especially after seeing the cases he presented, everyone's heads were buzzing.

"Holy crap, can it directly treat hepatitis B?"

"The indications for this lung cancer drug are incredible, right? A hundred billion dollars in sales is no longer a dream."

"Prevention is not a problem. The hepatitis B vaccine is very cheap now. The key is that it can directly treat multiple types of hepatitis B. This is the most amazing thing."

"This lung cancer drug is truly a miracle drug. I suspect there are many more indications that have yet to be discovered, as clinical trials won't test so many indications at once."

"That's amazing! No wonder Chen Xuan thinks the patent for a lung cancer drug is worth $1000 billion. With so many indications, that's not an exaggeration at all."

"In China alone, there are 50 million people infected with hepatitis B, and globally there are 2.35 million people infected with hepatitis B. Over one million people die from hepatitis B each year. How huge is this market?"

"It seems like the lung cancer drug already has hepatitis C treatment among its indications, and now it can even treat hepatitis B. Can't all liver-related diseases be cured by this new drug?"

This indication really shocked everyone.

The main reason is that the group of hepatitis B patients is too large.

A large group means a large market.

The profits involved are terrifying just to think about.

This made everyone no longer think that Chen Xuan's words were exaggerated.

1000 billion US dollars is really worth the price.